Progress of Bevacizumab in Malignant Pleural Effusion Caued by Non-small Cell Lung Cancer.
- Published in:
- Chinese Journal of Lung Cancer, 2019, v. 22, n. 2, p. 118, doi. 10.3779/j.issn.1009-3419.2019.02.07
- By:
- Publication type:
- Article
Works matching IS 10093419 AND DT 2019 AND VI 22 AND IP 2
Results: 7
1
2
Review on Treatment Modalities for Resectable IIIa/N2 Non-small Cell Lung Cancer.
- Published in:
- Chinese Journal of Lung Cancer, 2019, v. 22, n. 2, p. 111, doi. 10.3779/j.issn.1009-3419.2019.02.06
- By:
- Publication type:
- Article
3
Comparison of the Survival Time in the Non-small Cell Lung Cancer Patients with Different Organ Metastasis.
- Published in:
- Chinese Journal of Lung Cancer, 2019, v. 22, n. 2, p. 105, doi. 10.3779/j.issn.1009-3419.2019.02.05
- By:
- Publication type:
- Article
4
Clinical Predictive Factors associated with First Line EGFR-TKI Efficacy in Advanced NSCLC Patients with EGFR Mutations.
- Published in:
- Chinese Journal of Lung Cancer, 2019, v. 22, n. 2, p. 99, doi. 10.3779/j.issn.1009-3419.2019.02.04
- By:
- Publication type:
- Article
5
A Meta-Analysis of Efficacy and Adverse Effects of Lobaplatin and Cisplatin in the Treatment of Malignant Pleural Effusion.
- Published in:
- Chinese Journal of Lung Cancer, 2019, v. 22, n. 2, p. 90, doi. 10.3779/j.issn.1009-3419.2019.02.03
- By:
- Publication type:
- Article
6
MRTF-A Regulates the Proliferation and Migration of Non-small Cell Lung Cancer Cells of A549 through HOTAIR.
- Published in:
- Chinese Journal of Lung Cancer, 2019, v. 22, n. 2, p. 82, doi. 10.3779/j.issn.1009-3419.2019.02.02
- By:
- Publication type:
- Article
7
EGFR-TKI ADR Management Chinese Expert Consensus: Chinese Society of Lung Cancer, Chinese Anti-Cancer Association.
- Published in:
- Chinese Journal of Lung Cancer, 2019, v. 22, n. 2, p. 57, doi. 10.3779/j.issn.1009-3419.2019.02.01
- By:
- Publication type:
- Article